Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US.

Whichello C, van Overbeeke E, Janssens R, Schölin Bywall K, Russo S, Veldwijk J, Cleemput I, Juhaeri J, Levitan B, Kübler J, Smith M, Hermann R, Englbrecht M, Hueber AJ, Comanescu A, Harding S, Simoens S, Huys I, de Bekker-Grob EW.

Front Pharmacol. 2019 Sep 18;10:1009. doi: 10.3389/fphar.2019.01009. eCollection 2019.

2.

Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation-data from the prospective IVEPSA study.

Kampylafka E, Simon D, d'Oliveira I, Linz C, Lerchen V, Englbrecht M, Rech J, Kleyer A, Sticherling M, Schett G, Hueber AJ.

Arthritis Res Ther. 2019 Jul 26;21(1):178. doi: 10.1186/s13075-019-1957-0.

3.

[Flexor-tendon-injury of the hand].

Englbrecht MA, Frank K, Giunta RE.

MMW Fortschr Med. 2019 Jun;161(12):47-48. doi: 10.1007/s15006-019-0659-5. German. No abstract available.

PMID:
31230307
4.

Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA.

Janssens R, Russo S, van Overbeeke E, Whichello C, Harding S, Kübler J, Juhaeri J, Bywall KS, Comanescu A, Hueber A, Englbrecht M, Nikolenko N, Pravettoni G, Simoens S, Stevens H, Hermann R, Levitan B, Cleemput I, de Bekker-Grob E, Veldwijk J, Huys I.

Patient. 2019 Oct;12(5):513-526. doi: 10.1007/s40271-019-00367-w.

5.

New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II study.

Englbrecht M, Alten R, Aringer M, Baerwald CG, Burkhardt H, Eby N, Flacke JP, Fliedner G, Henkemeier U, Hofmann MW, Kleinert S, Kneitz C, Krüger K, Pohl C, Schett G, Schmalzing M, Tausche AK, Tony HP, Wendler J.

PLoS One. 2019 May 28;14(5):e0217412. doi: 10.1371/journal.pone.0217412. eCollection 2019.

6.

Perceptions of first-degree relatives of patients with rheumatoid arthritis about lifestyle modifications and pharmacological interventions to reduce the risk of rheumatoid arthritis development: a qualitative interview study.

Simons G, Stack RJ, Stoffer-Marx M, Englbrecht M, Mosor E, Buckley CD, Kumar K, Hansson M, Hueber A, Stamm T, Falahee M, Raza K.

BMC Rheumatol. 2018 Nov 6;2:31. doi: 10.1186/s41927-018-0038-3. eCollection 2018.

7.

I would never take preventive medication! Perspectives and information needs of people who underwent predictive tests for rheumatoid arthritis.

Mosor E, Stoffer-Marx M, Steiner G, Raza K, Stack RJ, Simons G, Falahee M, Skingle D, Dobrin M, Schett G, Englbrecht M, Smolen JS, Kjeken I, Hueber AJ, Stamm TA.

Arthritis Care Res (Hoboken). 2019 Feb 2. doi: 10.1002/acr.23841. [Epub ahead of print]

8.

Nerve transfer of the anterior interosseous nerve to the thenar branch of the median nerve - an anatomical and histological analysis.

Frank K, Englbrecht M, Koban KC, Cotofana SC, Stewart JK, Giunta RE, Schenck TL.

J Plast Reconstr Aesthet Surg. 2019 May;72(5):751-758. doi: 10.1016/j.bjps.2018.12.017. Epub 2018 Dec 15.

PMID:
30600157
9.

Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker Disease Activity Score and Autoantibody Status.

Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, Manger B, Figueiredo C, Cobra JF, Tony HP, Finzel S, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Lorenz HM, Nüsslein H, Alten R, Henes J, Krüger K, Schett G, Rech J.

J Rheumatol. 2019 May;46(5):460-466. doi: 10.3899/jrheum.180028. Epub 2018 Dec 1.

PMID:
30504510
10.

[Higher prevalence of depressive and anxiety symptoms in early arthritis patients in comparison to the normal population].

Freier D, Englbrecht M, Höhne-Zimmer V, Detert J, Burmester GR.

Z Rheumatol. 2019 Nov;78(9):820-831. doi: 10.1007/s00393-018-0571-x. German.

PMID:
30511171
11.

Simultaneous quantification of bone erosions and enthesiophytes in the joints of patients with psoriasis or psoriatic arthritis - effects of age and disease duration.

Simon D, Kleyer A, Faustini F, Englbrecht M, Haschka J, Berlin A, Kraus S, Hueber AJ, Kocijan R, Sticherling M, Rech J, Schett G.

Arthritis Res Ther. 2018 Aug 31;20(1):203. doi: 10.1186/s13075-018-1691-z.

12.

Cortical bone loss is an early feature of nonradiographic axial spondyloarthritis.

Neumann A, Haschka J, Kleyer A, Schuster L, Englbrecht M, Berlin A, Figueiredo CP, Simon D, Muschitz C, Kocijan R, Resch H, Rech J, Schett G.

Arthritis Res Ther. 2018 Aug 30;20(1):202. doi: 10.1186/s13075-018-1620-1.

13.

Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study.

Kampylafka E, d'Oliveira I, Linz C, Lerchen V, Stemmler F, Simon D, Englbrecht M, Sticherling M, Rech J, Kleyer A, Schett G, Hueber AJ.

Arthritis Res Ther. 2018 Jul 27;20(1):153. doi: 10.1186/s13075-018-1653-5.

14.

A comparative analysis of articular bone in large cohort of patients with chronic inflammatory diseases of the joints, the gut and the skin.

Simon D, Kleyer A, Englbrecht M, Stemmler F, Simon C, Berlin A, Kocijan R, Haschka J, Hirschmann S, Atreya R, Neurath MF, Sticherling M, Rech J, Hueber AJ, Engelke K, Schett G.

Bone. 2018 Nov;116:87-93. doi: 10.1016/j.bone.2018.07.017. Epub 2018 Jul 23.

PMID:
30048820
15.

Effects of ustekinumab versus tumor necrosis factor inhibition on enthesitis: Results from the enthesial clearance in psoriatic arthritis (ECLIPSA) study.

Araujo EG, Englbrecht M, Hoepken S, Finzel S, Kampylafka E, Kleyer A, Bayat S, Schoenau V, Hueber A, Rech J, Schett G.

Semin Arthritis Rheum. 2019 Feb;48(4):632-637. doi: 10.1016/j.semarthrit.2018.05.011. Epub 2018 Jun 13.

PMID:
30037432
16.

Biomechanical properties of bone are impaired in patients with ACPA-positive rheumatoid arthritis and associated with the occurrence of fractures.

Stemmler F, Simon D, Liphardt AM, Englbrecht M, Rech J, Hueber AJ, Engelke K, Schett G, Kleyer A.

Ann Rheum Dis. 2018 Jul;77(7):973-980. doi: 10.1136/annrheumdis-2017-212404. Epub 2018 Feb 23.

17.

Eosinophils are not essential for maintenance of murine plasma cells in the bone marrow.

Haberland K, Ackermann JA, Ipseiz N, Culemann S, Pracht K, Englbrecht M, Jäck HM, Schett G, Schuh W, Krönke G.

Eur J Immunol. 2018 May;48(5):822-828. doi: 10.1002/eji.201747227. Epub 2018 Mar 5.

18.

A novel multiplex detection array revealed systemic complement activation in oral squamous cell carcinoma.

Gallenkamp J, Spanier G, Wörle E, Englbrecht M, Kirschfink M, Greslechner R, Braun R, Schäfer N, Bauer RJ, Pauly D.

Oncotarget. 2017 Dec 6;9(3):3001-3013. doi: 10.18632/oncotarget.22963. eCollection 2018 Jan 9.

19.

Methods for segmentation of rheumatoid arthritis bone erosions in high-resolution peripheral quantitative computed tomography (HR-pQCT).

Figueiredo CP, Kleyer A, Simon D, Stemmler F, d'Oliveira I, Weissenfels A, Museyko O, Friedberger A, Hueber AJ, Haschka J, Englbrecht M, Pereira RMR, Rech J, Schett G, Engelke K.

Semin Arthritis Rheum. 2018 Apr;47(5):611-618. doi: 10.1016/j.semarthrit.2017.09.011. Epub 2017 Sep 23.

PMID:
29122245
20.

The revised Bristol Rheumatoid Arthritis Fatigue measures and the Rheumatoid Arthritis Impact of Disease scale: validation in six countries.

Hewlett S, Kirwan J, Bode C, Cramp F, Carmona L, Dures E, Englbrecht M, Fransen J, Greenwood R, Hagel S, van de Laar M, Molto A, Nicklin J, Petersson IF, Redondo M, Schett G, Gossec L.

Rheumatology (Oxford). 2018 Feb 1;57(2):300-308. doi: 10.1093/rheumatology/kex370.

21.

The value of 18F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study.

Schönau V, Vogel K, Englbrecht M, Wacker J, Schmidt D, Manger B, Kuwert T, Schett G.

Ann Rheum Dis. 2018 Jan;77(1):70-77. doi: 10.1136/annrheumdis-2017-211687. Epub 2017 Sep 19.

PMID:
28928271
22.

Early Changes of the Cortical Micro-Channel System in the Bare Area of the Joints of Patients With Rheumatoid Arthritis.

Werner D, Simon D, Englbrecht M, Stemmler F, Simon C, Berlin A, Haschka J, Renner N, Buder T, Engelke K, Hueber AJ, Rech J, Schett G, Kleyer A.

Arthritis Rheumatol. 2017 Aug;69(8):1580-1587. doi: 10.1002/art.40148. Epub 2017 Jun 26.

23.

Safety and efficacy of intravenous cyclophosphamide pulse therapy in therapy refractory Crohn's disease patients.

Hirschmann S, Atreya R, Englbrecht M, Neurath MF.

J Physiol Pharmacol. 2017 Feb;68(1):57-67.

24.

Development of three-dimensional prints of arthritic joints for supporting patients' awareness to structural damage.

Kleyer A, Beyer L, Simon C, Stemmler F, Englbrecht M, Beyer C, Rech J, Manger B, Krönke G, Schett G, Hueber AJ.

Arthritis Res Ther. 2017 Feb 10;19(1):34. doi: 10.1186/s13075-017-1234-z.

25.

Age- and Sex-Dependent Changes of Intra-articular Cortical and Trabecular Bone Structure and the Effects of Rheumatoid Arthritis.

Simon D, Kleyer A, Stemmler F, Simon C, Berlin A, Hueber AJ, Haschka J, Renner N, Figueiredo C, Neuhuber W, Buder T, Englbrecht M, Rech J, Engelke K, Schett G.

J Bone Miner Res. 2017 Apr;32(4):722-730. doi: 10.1002/jbmr.3025. Epub 2016 Nov 18.

26.

Validation of Standardized Questionnaires Evaluating Symptoms of Depression in Rheumatoid Arthritis Patients: Approaches to Screening for a Frequent Yet Underrated Challenge.

Englbrecht M, Alten R, Aringer M, Baerwald CG, Burkhardt H, Eby N, Fliedner G, Gauger B, Henkemeier U, Hofmann MW, Kleinert S, Kneitz C, Krueger K, Pohl C, Roske AE, Schett G, Schmalzing M, Tausche AK, Peter Tony H, Wendler J.

Arthritis Care Res (Hoboken). 2017 Jan;69(1):58-66. doi: 10.1002/acr.23002.

27.

Perceptions of risk and predictive testing held by the first-degree relatives of patients with rheumatoid arthritis in England, Austria and Germany: a qualitative study.

Stack RJ, Stoffer M, Englbrecht M, Mosor E, Falahee M, Simons G, Smolen J, Schett G, Buckley CD, Kumar K, Hansson M, Hueber A, Stamm T, Raza K.

BMJ Open. 2016 Jun 29;6(6):e010555. doi: 10.1136/bmjopen-2015-010555.

28.

Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs.

Figueiredo CP, Bang H, Cobra JF, Englbrecht M, Hueber AJ, Haschka J, Manger B, Kleyer A, Reiser M, Finzel S, Tony HP, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nuesslein H, Alten R, Henes J, Krueger K, Rech J, Schett G.

Ann Rheum Dis. 2017 Feb;76(2):399-407. doi: 10.1136/annrheumdis-2016-209297. Epub 2016 Jun 20.

PMID:
27323772
29.

Quantification and Impact of Secondary Osteoarthritis in Patients With Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis.

Figueiredo CP, Simon D, Englbrecht M, Haschka J, Kleyer A, Bayat S, Hueber A, Pereira RM, Rech J, Schett G.

Arthritis Rheumatol. 2016 Sep;68(9):2114-21. doi: 10.1002/art.39698.

30.

Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis.

Faustini F, Simon D, Oliveira I, Kleyer A, Haschka J, Englbrecht M, Cavalcante AR, Kraus S, Tabosa TP, Figueiredo C, Hueber AJ, Kocijan R, Cavallaro A, Schett G, Sticherling M, Rech J.

Ann Rheum Dis. 2016 Dec;75(12):2068-2074. doi: 10.1136/annrheumdis-2015-208821. Epub 2016 Feb 25.

PMID:
26916344
31.

High-resolution Quantitative Computed Tomography Demonstrates Structural Defects in Cortical and Trabecular Bone in IBD Patients.

Haschka J, Hirschmann S, Kleyer A, Englbrecht M, Faustini F, Simon D, Figueiredo CP, Schuster L, Muschitz C, Kocijan R, Resch H, Atreya R, Rech J, Neurath MF, Schett G.

J Crohns Colitis. 2016 May;10(5):532-40. doi: 10.1093/ecco-jcc/jjw012. Epub 2016 Jan 27.

32.

Prevalence of monosodium urate deposits in a population of rheumatoid arthritis patients with hyperuricemia.

Petsch C, Araujo EG, Englbrecht M, Bayat S, Cavallaro A, Hueber AJ, Lell M, Schett G, Manger B, Rech J.

Semin Arthritis Rheum. 2016 Jun;45(6):663-8. doi: 10.1016/j.semarthrit.2015.11.014. Epub 2015 Dec 2.

PMID:
26743072
33.
34.

Depression, Anxiety, Resilience and Coping Pre and Post Kidney Transplantation - Initial Findings from the Psychiatric Impairments in Kidney Transplantation (PI-KT)-Study.

Müller HH, Englbrecht M, Wiesener MS, Titze S, Heller K, Groemer TW, Schett G, Eckardt KU, Kornhuber J, Maler JM.

PLoS One. 2015 Nov 11;10(11):e0140706. doi: 10.1371/journal.pone.0140706. eCollection 2015.

35.

Tophus resolution with pegloticase: a prospective dual-energy CT study.

Araujo EG, Bayat S, Petsch C, Englbrecht M, Faustini F, Kleyer A, Hueber AJ, Cavallaro A, Lell M, Dalbeth N, Manger B, Schett G, Rech J.

RMD Open. 2015 Jun 17;1(1):e000075. doi: 10.1136/rmdopen-2015-000075. eCollection 2015.

36.

Presence of HLA-B27 is associated with changes of serum levels of mediators of the Wnt and hedgehog pathway.

Aschermann S, Englbrecht M, Bergua A, Spriewald BM, Said-Nahal R, Breban M, Schett G, Rech J.

Joint Bone Spine. 2016 Jan;83(1):43-6. doi: 10.1016/j.jbspin.2015.03.019. Epub 2015 Oct 19.

PMID:
26494593
37.

Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment.

Rech J, Hueber AJ, Finzel S, Englbrecht M, Haschka J, Manger B, Kleyer A, Reiser M, Cobra JF, Figueiredo C, Tony HP, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nuesslein H, Alten R, Henes J, Krueger K, Schett G.

Ann Rheum Dis. 2016 Sep;75(9):1637-44. doi: 10.1136/annrheumdis-2015-207900. Epub 2015 Oct 19.

38.

Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis.

Wohlfahrt T, Usherenko S, Englbrecht M, Dees C, Weber S, Beyer C, Gelse K, Distler O, Schett G, Distler JH, Ramming A.

Ann Rheum Dis. 2016 Mar;75(3):623-6. doi: 10.1136/annrheumdis-2015-207388. Epub 2015 Sep 2.

PMID:
26338035
39.

A comparative analysis of magnetic resonance imaging and high-resolution peripheral quantitative computed tomography of the hand for the detection of erosion repair in rheumatoid arthritis.

Regensburger A, Rech J, Englbrecht M, Finzel S, Kraus S, Hecht K, Kleyer A, Haschka J, Hueber AJ, Cavallaro A, Schett G, Faustini F.

Rheumatology (Oxford). 2015 Sep;54(9):1573-81. doi: 10.1093/rheumatology/kev031. Epub 2015 Mar 31.

PMID:
25832611
40.

Quantitative and Qualitative Changes of Bone in Psoriasis and Psoriatic Arthritis Patients.

Kocijan R, Englbrecht M, Haschka J, Simon D, Kleyer A, Finzel S, Kraus S, Resch H, Muschitz C, Engelke K, Sticherling M, Rech J, Schett G.

J Bone Miner Res. 2015 Oct;30(10):1775-83. doi: 10.1002/jbmr.2521. Epub 2015 May 10.

41.

Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.

Haschka J, Englbrecht M, Hueber AJ, Manger B, Kleyer A, Reiser M, Finzel S, Tony HP, Kleinert S, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Wendler J, Schuch F, Ronneberger M, Lorenz HM, Nuesslein H, Alten R, Demary W, Henes J, Schett G, Rech J.

Ann Rheum Dis. 2016 Jan;75(1):45-51. doi: 10.1136/annrheumdis-2014-206439. Epub 2015 Feb 6.

PMID:
25660991
42.

Analysis of periarticular bone changes in patients with cutaneous psoriasis without associated psoriatic arthritis.

Simon D, Faustini F, Kleyer A, Haschka J, Englbrecht M, Kraus S, Hueber AJ, Kocijan R, Sticherling M, Schett G, Rech J.

Ann Rheum Dis. 2016 Apr;75(4):660-6. doi: 10.1136/annrheumdis-2014-206347. Epub 2015 Feb 4.

PMID:
25653201
43.

High degree of nonadherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.

Rauscher V, Englbrecht M, van der Heijde D, Schett G, Hueber AJ.

J Rheumatol. 2015 Mar;42(3):386-90. doi: 10.3899/jrheum.140982. Epub 2015 Jan 15.

PMID:
25593229
44.

Treatment of vitiligo using targeted UVB-Intense Pulsed Light (IPL)- phototherapy: evaluation of variables affecting therapeutic success.

Hartmann A, Schmidt-Habel A, Löhberg L, Zajitschek J, Englbrecht M, Eichner S, Schuler G.

Eur J Dermatol. 2014 Sep-Oct;24(5):551-9. doi: 10.1684/ejd.2014.2398.

PMID:
25445089
45.

[Depression and rheumatism: options for measuring depression].

Englbrecht M, Wendler J, Alten R.

Z Rheumatol. 2014 Oct;73(8):714-20. doi: 10.1007/s00393-014-1414-z. German.

PMID:
25260818
46.

Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA.

Hecht C, Englbrecht M, Rech J, Schmidt S, Araujo E, Engelke K, Finzel S, Schett G.

Ann Rheum Dis. 2015 Dec;74(12):2151-6. doi: 10.1136/annrheumdis-2014-205428. Epub 2014 Aug 12.

PMID:
25115448
47.

Inflammatory bone spur formation in psoriatic arthritis is different from bone spur formation in hand osteoarthritis.

Finzel S, Sahinbegovic E, Kocijan R, Engelke K, Englbrecht M, Schett G.

Arthritis Rheumatol. 2014 Nov;66(11):2968-75. doi: 10.1002/art.38794.

48.

Semiquantitative measurements of capsular contracture with elastography--first results in correlation to Baker Score.

Prantl L, Englbrecht MA, Schoeneich M, Kuehlmann B, Jung EM, Kubale R.

Clin Hemorheol Microcirc. 2014;58(4):521-8. doi: 10.3233/CH-141812.

PMID:
24418866
49.

High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remission.

Araujo EG, Finzel S, Englbrecht M, Schreiber DA, Faustini F, Hueber A, Nas K, Rech J, Schett G.

Ann Rheum Dis. 2015 Apr;74(4):655-60. doi: 10.1136/annrheumdis-2013-204229. Epub 2013 Dec 12.

PMID:
24336010
50.

Decreased quantity and quality of the periarticular and nonperiarticular bone in patients with rheumatoid arthritis: a cross-sectional HR-pQCT study.

Kocijan R, Finzel S, Englbrecht M, Engelke K, Rech J, Schett G.

J Bone Miner Res. 2014 Apr;29(4):1005-14. doi: 10.1002/jbmr.2109.

Supplemental Content

Loading ...
Support Center